Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

NCT06501651 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

297

Enrollment

OTHER

Sponsor class

Conditions

Essential Hypertension
Type 2 Diabetes
Nephropathy

Interventions

DRUG: Sacubitril/Valsartan
DRUG: Valsartan

Sponsor

Sichuan Academy of Medical Sciences

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]